BioSpace News Archive

Gregg Alton, the former interim CEO of Gilead Sciences, a company he served in many key roles during his more than 20 year tenure

BeyondSpring Inc. announced the appointment of Dr. James Tonra, Ph.D. as Chief Science Officer, effective immediately. Dr. Tonra had previously served as Senior Vice President, Preclinical Development at BeyondSpring since April 2018.

Hillstream BioPharma Inc. (“Hillstream”) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to salinomycin based on nonclinical pharmacology data from HSB-1216 (QUATRAMER salinomycin), a new chemical entity for the treatment of small cell lung cancer.

Cytovia Therapeutics, a biopharmaceutical company, and the University of California, San Francisco (UCSF) announced today that they have entered a 3-year research partnership to develop novel precision gene editing to improve the performance, safety and persistence of Natural Killer (NK) cells and Chimeric Antigen Receptor (CAR)-NK cells.

Eiger BioPharmaceuticals, Inc. updated on progress across its product pipeline, including clinical and regulatory program planned milestones, and commercial preparation.

Inovio Pharmaceuticals, Inc. announced that Inovio’s President & CEO, Dr. J. Joseph Kim will present a corporate update of the company’s clinical program goals for 2020 at the Biotech Showcase 2020 Conference in San Francisco, CA.

Sexton Biotechnologies announced the launch of T-Liven-PR, a T-Cell validated Human Platelet Lysate shown to generate highly potent CAR-T Cells.

Akebia Therapeutics, Inc. announced that its President and Chief Executive Officer, John P. Butler, will present at the 38th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2020 at 9:30 a.m. PT in San Francisco.

Includes leading protein conjugation technologies and industry brands Lightning-Link® and CaptSure™

Revolutionary Modular Storage System Built to Efficiently Manage Enterprise, Cloud, and Edge Data Growth